Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I open-label pharmacokinetic interaction study of etravirine with fluconazole and voriconazole in healthy adults
NL-OMON32571Phase 1Active, not recruiting
- Sponsor
- Tibotec
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of etravirine, fluconazole and voriconazole in human immunodeficiency virus infection (HIV) and mycoses (2 arms), sponsored by Tibotec. Primary endpoint: Effect of steady-state voriconazole and fluconazole on steady-state pharmacokinetics of etravirine. Started Sep 2008; status: active, not recruiting.
02
Drugs
etravirinefluconazolevoriconazole
03
Conditions
human immunodeficiency virus infection (HIV)mycoses
Beyond the preview
Go deeper on NL-OMON32571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32571.